Non-infectious Macular Edema Treatment Market
1 Study Coverage
1.1 Non-infectious Macular Edema Treatment Revenue in Non-infectious Macular Edema Treatment Business (2017-2022) & (US$ Million) Introduction
1.2 Global Non-infectious Macular Edema Treatment Outlook 2017 VS 2022 VS 2028
1.2.1 Global Non-infectious Macular Edema Treatment Market Size for the Year 2017-2028
1.2.2 Global Non-infectious Macular Edema Treatment Market Size for the Year 2017-2028
1.3 Non-infectious Macular Edema Treatment Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.3.1 The Market Share of United States Non-infectious Macular Edema Treatment in Global, 2017 VS 2022 VS 2028
1.3.2 The Growth Rate of Non-infectious Macular Edema Treatment Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4 Non-infectious Macular Edema Treatment Market Dynamics
1.4.1 Non-infectious Macular Edema Treatment Industry Trends
1.4.2 Non-infectious Macular Edema Treatment Market Drivers
1.4.3 Non-infectious Macular Edema Treatment Market Challenges
1.4.4 Non-infectious Macular Edema Treatment Market Restraints
1.5 Study Objectives
1.6 Years Considered
2 Non-infectious Macular Edema Treatment by Type
2.1 Non-infectious Macular Edema Treatment Market Segment by Type
2.1.1 Anti-VEGF Therapy
2.1.2 Corticosteroid
2.1.3 Immune Inhibitor
2.1.4 Biological Preparation
2.1.5 Other
2.2 Global Non-infectious Macular Edema Treatment Market Size by Type (2017, 2022 & 2028)
2.3 Global Non-infectious Macular Edema Treatment Market Size by Type (2017-2028)
2.4 United States Non-infectious Macular Edema Treatment Market Size by Type (2017, 2022 & 2028)
2.5 United States Non-infectious Macular Edema Treatment Market Size by Type (2017-2028)
3 Non-infectious Macular Edema Treatment by Application
3.1 Non-infectious Macular Edema Treatment Market Segment by Application
3.1.1 Retail Pharmacy
3.1.2 Hospital Pharmacy
3.1.3 Other
3.2 Global Non-infectious Macular Edema Treatment Market Size by Application (2017, 2022 & 2028)
3.3 Global Non-infectious Macular Edema Treatment Market Size by Application (2017-2028)
3.4 United States Non-infectious Macular Edema Treatment Market Size by Application (2017, 2022 & 2028)
3.5 United States Non-infectious Macular Edema Treatment Market Size by Application (2017-2028)
4 Global Non-infectious Macular Edema Treatment Competitor Landscape by Company
4.1 Global Non-infectious Macular Edema Treatment Market Size by Company
4.1.1 Top Global Non-infectious Macular Edema Treatment Companies Ranked by Revenue (2021)
4.1.2 Global Non-infectious Macular Edema Treatment Revenue by Player (2017-2022)
4.2 Global Non-infectious Macular Edema Treatment Concentration Ratio (CR)
4.2.1 Non-infectious Macular Edema Treatment Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Companies of Non-infectious Macular Edema Treatment in 2021
4.2.3 Global Non-infectious Macular Edema Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Non-infectious Macular Edema Treatment Headquarters, Revenue in Non-infectious Macular Edema Treatment Business (2017-2022) & (US$ Million) Type
4.3.1 Global Non-infectious Macular Edema Treatment Headquarters and Area Served
4.3.2 Global Non-infectious Macular Edema Treatment Companies Revenue in Non-infectious Macular Edema Treatment Business (2017-2022) & (US$ Million) Type
4.3.3 Date of International Companies Enter into Non-infectious Macular Edema Treatment Market
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 United States Non-infectious Macular Edema Treatment Market Size by Company
4.5.1 Top Non-infectious Macular Edema Treatment Players in United States, Ranked by Revenue (2021)
4.5.2 United States Non-infectious Macular Edema Treatment Revenue by Players (2020, 2021 & 2022)
5 Global Non-infectious Macular Edema Treatment Market Size by Region
5.1 Global Non-infectious Macular Edema Treatment Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Non-infectious Macular Edema Treatment Market Size by Region (2017-2028)
5.2.1 Global Non-infectious Macular Edema Treatment Market Size by Region: 2017-2022
5.2.2 Global Non-infectious Macular Edema Treatment Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Non-infectious Macular Edema Treatment Market Size YoY Growth 2017-2028
6.1.2 North America Non-infectious Macular Edema Treatment Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Non-infectious Macular Edema Treatment Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Non-infectious Macular Edema Treatment Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Non-infectious Macular Edema Treatment Market Size YoY Growth 2017-2028
6.3.2 Europe Non-infectious Macular Edema Treatment Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Non-infectious Macular Edema Treatment Market Size YoY Growth 2017-2028
6.4.2 Latin America Non-infectious Macular Edema Treatment Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Non-infectious Macular Edema Treatment Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Non-infectious Macular Edema Treatment Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Allergan
7.1.1 Allergan Company Details
7.1.2 Allergan Business Overview
7.1.3 Allergan Non-infectious Macular Edema Treatment Introduction
7.1.4 Allergan Revenue in Non-infectious Macular Edema Treatment Business (2017-2022)
7.1.5 Allergan Recent Development
7.2 Amgen
7.2.1 Amgen Company Details
7.2.2 Amgen Business Overview
7.2.3 Amgen Non-infectious Macular Edema Treatment Introduction
7.2.4 Amgen Revenue in Non-infectious Macular Edema Treatment Business (2017-2022)
7.2.5 Amgen Recent Development
7.3 Pfizer
7.3.1 Pfizer Company Details
7.3.2 Pfizer Business Overview
7.3.3 Pfizer Non-infectious Macular Edema Treatment Introduction
7.3.4 Pfizer Revenue in Non-infectious Macular Edema Treatment Business (2017-2022)
7.3.5 Pfizer Recent Development
7.4 Novartis AG
7.4.1 Novartis AG Company Details
7.4.2 Novartis AG Business Overview
7.4.3 Novartis AG Non-infectious Macular Edema Treatment Introduction
7.4.4 Novartis AG Revenue in Non-infectious Macular Edema Treatment Business (2017-2022)
7.4.5 Novartis AG Recent Development
7.5 F. Hoffman-La Roche
7.5.1 F. Hoffman-La Roche Company Details
7.5.2 F. Hoffman-La Roche Business Overview
7.5.3 F. Hoffman-La Roche Non-infectious Macular Edema Treatment Introduction
7.5.4 F. Hoffman-La Roche Revenue in Non-infectious Macular Edema Treatment Business (2017-2022)
7.5.5 F. Hoffman-La Roche Recent Development
7.6 AbbVie
7.6.1 AbbVie Company Details
7.6.2 AbbVie Business Overview
7.6.3 AbbVie Non-infectious Macular Edema Treatment Introduction
7.6.4 AbbVie Revenue in Non-infectious Macular Edema Treatment Business (2017-2022)
7.6.5 AbbVie Recent Development
7.7 Bayer AG
7.7.1 Bayer AG Company Details
7.7.2 Bayer AG Business Overview
7.7.3 Bayer AG Non-infectious Macular Edema Treatment Introduction
7.7.4 Bayer AG Revenue in Non-infectious Macular Edema Treatment Business (2017-2022)
7.7.5 Bayer AG Recent Development
7.8 Valeant Pharmaceuticals
7.8.1 Valeant Pharmaceuticals Company Details
7.8.2 Valeant Pharmaceuticals Business Overview
7.8.3 Valeant Pharmaceuticals Non-infectious Macular Edema Treatment Introduction
7.8.4 Valeant Pharmaceuticals Revenue in Non-infectious Macular Edema Treatment Business (2017-2022)
7.8.5 Valeant Pharmaceuticals Recent Development
7.9 Alimera Sciences
7.9.1 Alimera Sciences Company Details
7.9.2 Alimera Sciences Business Overview
7.9.3 Alimera Sciences Non-infectious Macular Edema Treatment Introduction
7.9.4 Alimera Sciences Revenue in Non-infectious Macular Edema Treatment Business (2017-2022)
7.9.5 Alimera Sciences Recent Development
7.10 Clearside Biomedical
7.10.1 Clearside Biomedical Company Details
7.10.2 Clearside Biomedical Business Overview
7.10.3 Clearside Biomedical Non-infectious Macular Edema Treatment Introduction
7.10.4 Clearside Biomedical Revenue in Non-infectious Macular Edema Treatment Business (2017-2022)
7.10.5 Clearside Biomedical Recent Development
8 Research Findings and Conclusion
9 Appendix
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Author Details
9.3 Disclaimer
List of Tables
Table 1. Non-infectious Macular Edema Treatment Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
Table 2. Non-infectious Macular Edema Treatment Market Trends
Table 3. Non-infectious Macular Edema Treatment Market Drivers
Table 4. Non-infectious Macular Edema Treatment Market Challenges
Table 5. Non-infectious Macular Edema Treatment Market Restraints
Table 6. Global Non-infectious Macular Edema Treatment Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Non-infectious Macular Edema Treatment Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Non-infectious Macular Edema Treatment Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Non-infectious Macular Edema Treatment Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Non-infectious Macular Edema Treatment Companies in Global Market, Ranking by Revenue (2021)
Table 11. Global Non-infectious Macular Edema Treatment Revenue by Player, (US$ Million), 2017-2022
Table 12. Global Non-infectious Macular Edema Treatment Revenue Share by Player, 2017-2022
Table 13. Global Non-infectious Macular Edema Treatment Companies Market Concentration Ratio (CR5 and HHI)
Table 14. Global Non-infectious Macular Edema Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-infectious Macular Edema Treatment as of 2021)
Table 15. Top Players of Non-infectious Macular Edema Treatment in Global Market, Headquarters and Area Served
Table 16. Companies Revenue in Non-infectious Macular Edema Treatment Business (2017-2022) & (US$ Million) Type
Table 17. Date of International Companies Enter into Non-infectious Macular Edema Treatment Market
Table 18. Companies Mergers & Acquisitions, Expansion Plans
Table 19. Top Non-infectious Macular Edema Treatment Players in United States Market, Ranking by Revenue (2021)
Table 20. United States Non-infectious Macular Edema Treatment Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 21. United States Non-infectious Macular Edema Treatment Revenue Share by Players, 2020, 2021 & 2022
Table 22. Global Non-infectious Macular Edema Treatment Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 23. Global Non-infectious Macular Edema Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 24. Global Non-infectious Macular Edema Treatment Market Size Forecast by Region (2023-2028) & (US$ Million)
Table 25. North America Non-infectious Macular Edema Treatment Sales in Value by Country (2017-2028) & (US$ Million)
Table 26. Asia Pacific Non-infectious Macular Edema Treatment Sales in Value by Region (2017-2028) & (US$ Million)
Table 27. Europe Non-infectious Macular Edema Treatment Sales in Value by Country (2017-2028) & (US$ Million)
Table 28. Latin Americaa Non-infectious Macular Edema Treatment Sales in Value by Country (2017-2028) & (US$ Million)
Table 29. Middle East and Africa Non-infectious Macular Edema Treatment Sales in Value by Country (2017-2028) & (US$ Million)
Table 30. Allergan Company Details
Table 31. Allergan Business Overview
Table 32. Allergan Non-infectious Macular Edema Treatment Product
Table 33. Allergan Revenue in Non-infectious Macular Edema Treatment Business (2017-2022) & (US$ Million)
Table 34. Allergan Recent Development
Table 35. Amgen Company Details
Table 36. Amgen Business Overview
Table 37. Amgen Non-infectious Macular Edema Treatment Product
Table 38. Amgen Revenue in Non-infectious Macular Edema Treatment Business (2017-2022) & (US$ Million)
Table 39. Amgen Recent Development
Table 40. Pfizer Company Details
Table 41. Pfizer Business Overview
Table 42. Pfizer Non-infectious Macular Edema Treatment Product
Table 43. Pfizer Revenue in Non-infectious Macular Edema Treatment Business (2017-2022) & (US$ Million)
Table 44. Pfizer Recent Development
Table 45. Novartis AG Company Details
Table 46. Novartis AG Business Overview
Table 47. Novartis AG Non-infectious Macular Edema Treatment Product
Table 48. Novartis AG Revenue in Non-infectious Macular Edema Treatment Business (2017-2022) & (US$ Million)
Table 49. Novartis AG Recent Development
Table 50. F. Hoffman-La Roche Company Details
Table 51. F. Hoffman-La Roche Business Overview
Table 52. F. Hoffman-La Roche Non-infectious Macular Edema Treatment Product
Table 53. F. Hoffman-La Roche Revenue in Non-infectious Macular Edema Treatment Business (2017-2022) & (US$ Million)
Table 54. F. Hoffman-La Roche Recent Development
Table 55. AbbVie Company Details
Table 56. AbbVie Business Overview
Table 57. AbbVie Non-infectious Macular Edema Treatment Product
Table 58. AbbVie Revenue in Non-infectious Macular Edema Treatment Business (2017-2022) & (US$ Million)
Table 59. AbbVie Recent Development
Table 60. Bayer AG Company Details
Table 61. Bayer AG Business Overview
Table 62. Bayer AG Non-infectious Macular Edema Treatment Product
Table 63. Bayer AG Revenue in Non-infectious Macular Edema Treatment Business (2017-2022) & (US$ Million)
Table 64. Bayer AG Recent Development
Table 65. Valeant Pharmaceuticals Company Details
Table 66. Valeant Pharmaceuticals Business Overview
Table 67. Valeant Pharmaceuticals Non-infectious Macular Edema Treatment Product
Table 68. Valeant Pharmaceuticals Revenue in Non-infectious Macular Edema Treatment Business (2017-2022) & (US$ Million)
Table 69. Valeant Pharmaceuticals Recent Development
Table 70. Alimera Sciences Company Details
Table 71. Alimera Sciences Business Overview
Table 72. Alimera Sciences Non-infectious Macular Edema Treatment Product
Table 73. Alimera Sciences Revenue in Non-infectious Macular Edema Treatment Business (2017-2022) & (US$ Million)
Table 74. Alimera Sciences Recent Development
Table 75. Clearside Biomedical Company Details
Table 76. Clearside Biomedical Business Overview
Table 77. Clearside Biomedical Non-infectious Macular Edema Treatment Product
Table 78. Clearside Biomedical Revenue in Non-infectious Macular Edema Treatment Business (2017-2022) & (US$ Million)
Table 79. Clearside Biomedical Recent Development
Table 80. Research Programs/Design for This Report
Table 81. Key Data Information from Secondary Sources
Table 82. Key Data Information from Primary Sources
List of Figures
Figure 1. Non-infectious Macular Edema Treatment Product Picture
Figure 2. Global Non-infectious Macular Edema Treatment Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Non-infectious Macular Edema Treatment Market Size 2017-2028 (US$ Million)
Figure 4. United States Non-infectious Macular Edema Treatment Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 5. United States Non-infectious Macular Edema Treatment Market Size 2017-2028 (US$ Million)
Figure 6. United States Non-infectious Macular Edema Treatment Market Share in Global 2017-2028
Figure 7. Non-infectious Macular Edema Treatment Report Years Considered
Figure 8. Product Picture of Anti-VEGF Therapy
Figure 9. Product Picture of Corticosteroid
Figure 10. Product Picture of Immune Inhibitor
Figure 11. Product Picture of Biological Preparation
Figure 12. Product Picture of Other
Figure 13. Global Non-infectious Macular Edema Treatment Market Share by Type in 2022 & 2028
Figure 14. Global Non-infectious Macular Edema Treatment Market Size by Type (2017-2028) & (US$ Million)
Figure 15. Global Non-infectious Macular Edema Treatment Market Share by Type (2017-2028)
Figure 16. United States Non-infectious Macular Edema Treatment Market Share by Type in 2022 & 2028
Figure 17. United States Non-infectious Macular Edema Treatment Market Size by Type (2017-2028) & (US$ Million)
Figure 18. United States Non-infectious Macular Edema Treatment Market Share by Type (2017-2028)
Figure 19. Product Picture of Retail Pharmacy
Figure 20. Product Picture of Hospital Pharmacy
Figure 21. Product Picture of Other
Figure 22. Global Non-infectious Macular Edema Treatment Market Share by Application in 2022 & 2028
Figure 23. Global Non-infectious Macular Edema Treatment Market Size by Application (2017-2028) & (US$ Million)
Figure 24. Global Non-infectious Macular Edema Treatment Market Share by Application (2017-2028)
Figure 25. United States Non-infectious Macular Edema Treatment Market Share by Application in 2022 & 2028
Figure 26. United States Non-infectious Macular Edema Treatment Market Size by Application (2017-2028) & (US$ Million)
Figure 27. United States Non-infectious Macular Edema Treatment Market Share by Application (2017-2028)
Figure 28. North America Non-infectious Macular Edema Treatment Market Size Growth Rate 2017-2028 (US$ Million)
Figure 29. U.S. Non-infectious Macular Edema Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 30. Canada Non-infectious Macular Edema Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 31. Europe Non-infectious Macular Edema Treatment Market Size Growth Rate 2017-2028 (US$ Million)
Figure 32. Germany Non-infectious Macular Edema Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 33. France Non-infectious Macular Edema Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 34. U.K. Non-infectious Macular Edema Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 35. Italy Non-infectious Macular Edema Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 36. Russia Non-infectious Macular Edema Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 37. Asia-Pacific Non-infectious Macular Edema Treatment Market Size Growth Rate 2017-2028 (US$ Million)
Figure 38. China Non-infectious Macular Edema Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 39. Japan Non-infectious Macular Edema Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 40. South Korea Non-infectious Macular Edema Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 41. India Non-infectious Macular Edema Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 42. Australia Non-infectious Macular Edema Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 43. Taiwan Non-infectious Macular Edema Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 44. Indonesia Non-infectious Macular Edema Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 45. Thailand Non-infectious Macular Edema Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 46. Malaysia Non-infectious Macular Edema Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 47. Philippines Non-infectious Macular Edema Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 48. Latin America Non-infectious Macular Edema Treatment Market Size Growth Rate 2017-2028 (US$ Million)
Figure 49. Mexico Non-infectious Macular Edema Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 50. Brazil Non-infectious Macular Edema Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 51. Argentina Non-infectious Macular Edema Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 52. Middle East & Africa Non-infectious Macular Edema Treatment Market Size Growth Rate 2017-2028 (US$ Million)
Figure 53. Turkey Non-infectious Macular Edema Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 54. Saudi Arabia Non-infectious Macular Edema Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 55. U.A.E Non-infectious Macular Edema Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 56. Allergan Revenue Growth Rate in Non-infectious Macular Edema Treatment Business (2017-2022)
Figure 57. Amgen Revenue Growth Rate in Non-infectious Macular Edema Treatment Business (2017-2022)
Figure 58. Pfizer Revenue Growth Rate in Non-infectious Macular Edema Treatment Business (2017-2022)
Figure 59. Novartis AG Revenue Growth Rate in Non-infectious Macular Edema Treatment Business (2017-2022)
Figure 60. F. Hoffman-La Roche Revenue Growth Rate in Non-infectious Macular Edema Treatment Business (2017-2022)
Figure 61. AbbVie Revenue Growth Rate in Non-infectious Macular Edema Treatment Business (2017-2022)
Figure 62. Bayer AG Revenue Growth Rate in Non-infectious Macular Edema Treatment Business (2017-2022)
Figure 63. Valeant Pharmaceuticals Revenue Growth Rate in Non-infectious Macular Edema Treatment Business (2017-2022)
Figure 64. Alimera Sciences Revenue Growth Rate in Non-infectious Macular Edema Treatment Business (2017-2022)
Figure 65. Clearside Biomedical Revenue Growth Rate in Non-infectious Macular Edema Treatment Business (2017-2022)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Industry Market Size
